Explore more publications!
Today in Medicine
Got News to Share?

Press Releases

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
Feb. 18, 2026

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm

Indeterminate GlobeNewswire, Inc.
Attor­ney Gen­er­al Ken Pax­ton Files Land­mark Law­suit Against Children’s Health and Dal­las-Area Doc­tor for Hurt­ing Kids by Ille­gal­ly ​“Tran­si­tion­ing” Them and Defraud­ing Medicaid
Feb. 18, 2026

Attor­ney Gen­er­al Ken Pax­ton Files Land­mark Law­suit Against Children’s Health and Dal­las-Area Doc­tor for Hurt­ing Kids by Ille­gal­ly ​“Tran­si­tion­ing” Them and Defraud­ing Medicaid

Gov't Institution Attorney General of Texas
Owner: American Government

Attorney General of Texas

Gov't Institution
Owned By American Government
Year Founded 1836
Website https://www.texasattorneygeneral.gov/
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, Texas, Austin
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Feb. 18, 2026

Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

Indeterminate GlobeNewswire, Inc.
Acrivon Therapeutics Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory
Feb. 18, 2026

Acrivon Therapeutics Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory

Indeterminate GlobeNewswire, Inc.
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
Feb. 18, 2026

Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference

Indeterminate GlobeNewswire, Inc.
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
Feb. 18, 2026

NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire, Inc.
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
Feb. 18, 2026

Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830

Indeterminate GlobeNewswire, Inc.
Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State
Feb. 18, 2026

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Indeterminate GlobeNewswire, Inc.
Gideon Korrell Examines Merck Serono v. Hopewell Pharma Ventures’ Impact on 'By Another'
Feb. 18, 2026

Gideon Korrell Examines Merck Serono v. Hopewell Pharma Ventures’ Impact on 'By Another'

Neutral EIN Presswire
Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk
Feb. 10, 2026

Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk

Indeterminate GlobeNewswire, Inc.
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Feb. 17, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire, Inc.
DHS Sets the Record Straight on New York Time’s FALSE Claims Regarding Medical Care at ICE Detention Facilities
Feb. 18, 2026

DHS Sets the Record Straight on New York Time’s FALSE Claims Regarding Medical Care at ICE Detention Facilities

Gov't Institution Department of Homeland Security - Washington D.C.
Owner: American Government

Department of Homeland Security - Washington, D.C.

Gov't Institution
Owned By American Government
Year Founded 2002
Website www.dhs.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, District of Columbia, Washington, D.C.
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

WIRX Pharmacy Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
Feb. 18, 2026

WIRX Pharmacy Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims

Indeterminate GlobeNewswire, Inc.
Onspire Health Marketing Releases New Report: 2026 Marketing Trends for Medical Practices
Feb. 17, 2026

Onspire Health Marketing Releases New Report: 2026 Marketing Trends for Medical Practices

Indeterminate GlobeNewswire, Inc.
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Feb. 17, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire, Inc.
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Feb. 17, 2026

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Indeterminate GlobeNewswire, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
Feb. 17, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON

Indeterminate GlobeNewswire, Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Picard Medical, Inc. of Class Action Lawsuit and Upcoming Deadlines – PMI
Feb. 17, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Picard Medical, Inc. of Class Action Lawsuit and Upcoming Deadlines – PMI

Indeterminate GlobeNewswire, Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE
Feb. 17, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE

Indeterminate GlobeNewswire, Inc.
Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio
Feb. 17, 2026

Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions